Advertisement
U.S. markets open in 4 hours 37 minutes

ICL Group Ltd (ICL.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA (0.01 ILS)
1,859.00+9.00 (+0.49%)
As of 10:38AM IST. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1,850.00
Open1,799.00
Bid1,770.00 x 20100
Ask1,781.00 x 1591600
Day's Range1,850.00 - 1,864.00
52 Week Range1,629.00 - 2,500.00
Volume284,382
Avg. Volume1,855,786
Market Cap23.973B
Beta (5Y Monthly)0.58
PE Ratio (TTM)9.68
EPS (TTM)1.92
Earnings DateMay 08, 2024 - May 13, 2024
Forward Dividend & Yield0.70 (3.77%)
Ex-Dividend DateMar 14, 2024
1y Target Est5.42
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ICL.TA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Business Wire

      ICL Files 2023 Annual Report on Form 20-F

      TEL AVIV, Israel, March 14, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (SEC). Included, for the third year in a row, are Task Force on Climate-related Financial Disclosures (TCFD), which provide information on what ICL is doing to mitigate the risks of climate change and reduce its carbon footprint.

    • Business Wire

      ICL Accelerating Biologicals Portfolio Growth in Brazil with Strategic Acquisition

      TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it has acquired Nitro 1000, a manufacturer, developer and provider of biologicals in Brazil for approximately $30 million. This acquisition marks another meaningful step into the biologicals market, while expanding ICL’s product offerings and positioning the company for further expansions into new and adjacent end-markets.

    • Business Wire

      ICL Reports Fourth Quarter and Full Year 2023 Results

      TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Consolidated annual sales were $7,536 million versus a record $10,015 million in 2022. Net income was $647 million versus $2,159 million, while adjusted net income was $715 million versus $2,350 million. Annual adjusted EBITDA was $1,754 million versus $4,007 million in 2022. Diluted earni